The medical schemes industry reported a R820.5m surplus in 2021, as members postponed treatment when coronavirus infections surged but did not put off treatment to the same extent as the year before, according to the latest Council for Medical Schemes (CMS) annual report.

While many schemes reported a rise in claims expenditure in 2021 compared with 2020’s historic lows they were again able to defer annual contribution increases or announce unusually modest, subinflation rate increases thanks to the cash pile of almost R2bn they amassed in 2020...

Subscribe now to unlock this article.

Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).

There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.

Cancel anytime.

Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.

Speech Bubbles

Please read our Comment Policy before commenting.